ATR activation is regulated by dimerization of ATR activating proteins.


Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
Historique:
received: 07 12 2020
revised: 17 02 2021
accepted: 22 02 2021
pubmed: 27 2 2021
medline: 31 8 2021
entrez: 26 2 2021
Statut: ppublish

Résumé

The checkpoint kinase ATR regulates DNA repair, cell cycle progression, and other DNA damage and replication stress responses. ATR signaling is stimulated by an ATR activating protein, and in metazoan cells, there are at least two ATR activators: TOPBP1 and ETAA1. Current evidence indicates TOPBP1 and ETAA1 activate ATR via the same biochemical mechanism, but several aspects of this mechanism remain undefined. For example, ATR and its obligate binding partner ATR interacting protein (ATRIP) form a tetrameric complex consisting of two ATR and two ATRIP molecules, but whether TOPBP1 or ETAA1 dimerization is similarly required for ATR function is unclear. Here, we show that fusion of the TOPBP1 and ETAA1 ATR activation domains (AADs) to dimeric tags makes them more potent activators of ATR in vitro. Furthermore, induced dimerization of both AADs using chemical dimerization of a modified FKBP tag enhances ATR kinase activation and signaling in cells. ETAA1 forms oligomeric complexes mediated by regions of the protein that are predicted to be intrinsically disordered. Induced dimerization of a "mini-ETAA1" protein that contains the AAD and Replication Protein A (RPA) interaction motifs enhances ATR signaling, rescues cellular hypersensitivity to DNA damaging agents, and suppresses micronuclei formation in ETAA1-deficient cells. Together, our results indicate that TOPBP1 and ETAA1 dimerization is important for optimal ATR signaling and genome stability.

Identifiants

pubmed: 33636182
pii: S0021-9258(21)00228-3
doi: 10.1016/j.jbc.2021.100455
pmc: PMC7994790
pii:
doi:

Substances chimiques

ATRIP protein, human 0
Adaptor Proteins, Signal Transducing 0
Antigens, Surface 0
Carrier Proteins 0
Cell Cycle Proteins 0
DNA-Binding Proteins 0
ETAA1 protein, human 0
Nuclear Proteins 0
TOPBP1 protein, human 0
ATR protein, human EC 2.7.11.1
Ataxia Telangiectasia Mutated Proteins EC 2.7.11.1

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

100455

Subventions

Organisme : NCI NIH HHS
ID : P50 CA098131
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA239161
Pays : United States

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article.

Références

J Biol Chem. 2013 May 3;288(18):12840-51
pubmed: 23525106
Science. 2017 Dec 1;358(6367):1206-1209
pubmed: 29191911
Cell. 2006 Mar 10;124(5):943-55
pubmed: 16530042
J Cell Biol. 2019 Apr 1;218(4):1235-1249
pubmed: 30755469
Genes Dev. 2008 Jun 1;22(11):1478-89
pubmed: 18519640
Nat Cell Biol. 2016 Nov;18(11):1196-1207
pubmed: 27723717
Mol Cell. 2021 Mar 18;81(6):1231-1245.e8
pubmed: 33503405
EMBO J. 2006 Oct 18;25(20):4795-807
pubmed: 17006541
Mol Cell. 2015 Sep 17;59(6):1011-24
pubmed: 26365377
Science. 2001 Nov 23;294(5547):1713-6
pubmed: 11721054
DNA Repair (Amst). 2020 Dec;96:102973
pubmed: 32987353
Mol Cell. 2019 Jun 6;74(5):866-876
pubmed: 31173722
J Biol Chem. 2016 Jun 24;291(26):13436-47
pubmed: 27129217
Annu Rev Biochem. 2018 Jun 20;87:263-294
pubmed: 29709199
J Mol Biol. 1995 Feb 10;246(1):21-7
pubmed: 7853399
Genes Dev. 2013 Feb 1;27(3):313-21
pubmed: 23355394
Curr Biol. 2016 Dec 19;26(24):3257-3268
pubmed: 27818175
J Cell Biol. 2019 Dec 2;218(12):3943-3953
pubmed: 31615875
PLoS Genet. 2013;9(8):e1003702
pubmed: 23950734
Science. 2018 Aug 24;361(6404):806-810
pubmed: 30139873
Nat Cell Biol. 2016 Nov;18(11):1185-1195
pubmed: 27723720
J Biol Chem. 2008 Dec 19;283(51):35853-9
pubmed: 18922789
Nat Rev Mol Cell Biol. 2017 May;18(5):285-298
pubmed: 28225081
Science. 2004 Apr 2;304(5667):93-6
pubmed: 15064416
Science. 2003 Jun 6;300(5625):1542-8
pubmed: 12791985
Nat Rev Mol Cell Biol. 2017 Oct;18(10):622-636
pubmed: 28811666
Mol Cell Biol. 2013 Dec;33(23):4685-700
pubmed: 24081328
J Biol Chem. 2019 May 24;294(21):8395-8402
pubmed: 30940728
Science. 2005 Apr 22;308(5721):551-4
pubmed: 15790808
Proc Natl Acad Sci U S A. 2008 Dec 2;105(48):18730-4
pubmed: 19028869
Science. 2018 Jan 5;359(6371):108-114
pubmed: 29170278
J Biol Chem. 2005 Sep 9;280(36):31390-6
pubmed: 16027118
Nat Struct Mol Biol. 2021 Jan;28(1):50-61
pubmed: 33169019
Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10437-42
pubmed: 9724721
Nat Commun. 2016 May 27;7:11655
pubmed: 27229179
Mol Cell. 2009 Dec 11;36(5):743-53
pubmed: 20005839
Cell Res. 2018 Feb;28(2):143-156
pubmed: 29271416

Auteurs

Vaughn Thada (V)

Department of Biochemistry, Vanderbilt University School of Medicine, Nashville Tennessee, USA.

David Cortez (D)

Department of Biochemistry, Vanderbilt University School of Medicine, Nashville Tennessee, USA. Electronic address: david.cortez@vanderbilt.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH